Corteva, Inc. $CTVA Position Trimmed by Hsbc Holdings PLC

Hsbc Holdings PLC lowered its stake in Corteva, Inc. (NYSE:CTVA) by 11.6% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,354,768 shares of the company’s stock after selling 178,269 shares during the period. Hsbc Holdings PLC’s holdings in Corteva were worth $90,950,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently modified their holdings of CTVA. Harris Associates L P lifted its holdings in shares of Corteva by 168.1% during the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock valued at $1,141,268,000 after purchasing an additional 10,675,052 shares during the last quarter. Norges Bank purchased a new position in Corteva in the 4th quarter worth about $504,001,000. Northwestern Mutual Wealth Management Co. raised its holdings in Corteva by 6,527.4% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,148,212 shares of the company’s stock worth $211,025,000 after buying an additional 3,100,709 shares during the period. Perpetual Ltd raised its holdings in Corteva by 78,688.5% during the 4th quarter. Perpetual Ltd now owns 2,615,779 shares of the company’s stock worth $175,336,000 after buying an additional 2,612,459 shares during the period. Finally, Amundi lifted its stake in Corteva by 125.3% during the third quarter. Amundi now owns 3,415,554 shares of the company’s stock valued at $219,620,000 after buying an additional 1,899,248 shares in the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Trading Down 0.2%

NYSE:CTVA opened at $85.63 on Friday. The stock has a market cap of $57.27 billion, a PE ratio of 50.37, a price-to-earnings-growth ratio of 2.62 and a beta of 0.56. Corteva, Inc. has a fifty-two week low of $60.53 and a fifty-two week high of $85.95. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03. The stock’s 50-day moving average is $79.80 and its two-hundred day moving average is $76.86.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. The business had revenue of $4.91 billion during the quarter, compared to analyst estimates of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The firm’s revenue was up 11.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.13 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities research analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Monday, June 1st were given a $0.18 dividend. The ex-dividend date was Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.8%. Corteva’s dividend payout ratio is presently 42.35%.

Analysts Set New Price Targets

Several research analysts have commented on CTVA shares. Oppenheimer raised their target price on shares of Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a report on Wednesday, April 22nd. Jefferies Financial Group upped their price target on shares of Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. UBS Group decreased their price objective on shares of Corteva from $90.00 to $86.00 and set a “neutral” rating for the company in a research note on Tuesday, June 9th. BNP Paribas Exane lifted their price objective on shares of Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. Finally, Weiss Ratings raised shares of Corteva from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, May 7th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $88.90.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.